{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Covid-19", "Lung anti-inflammatory", "SARS-CoV-2", "Traditional Persian medicine", "Viola odorata L.", "Violet syrup"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36535329", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "06"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2022.116058", "S0378-8741(22)01097-2"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "304", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "25"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial.", "Pagination": {"StartPage": "116058", "MedlinePgn": "116058"}, "Abstract": {"AbstractText": ["Severe Acute Respiratory Syndrome (SARS) due to the novel coronavirus has become the highest priority that threatens human health. This situation demands widespread vaccination and the innovation of new therapeutic methods. Despite drug discoveries, the need for approving new medicaments is felt because of adverse effects and lack of efficacy. Several medicinal plants including Viola odorata L. are recommended in traditional Persian medicine for alleviating respiratory infection symptoms. Recent studies showed anti-inflammatory, antioxidant, anti-asthmatic, antitussive, analgesic, and antibacterial activities of sweet violet. These enhance respiratory functions, reduce pulmonary inflammation, and decline mucous membrane edema. This study aimed to evaluate the efficacy of sweet violet syrup in alleviating the manifestations of COVID-19 infection.", "A randomized parallel-group double-blind controlled trial was conducted at Al-Zahra general hospital, Isfahan, Iran. A total of 108 outpatients were enrolled in the study. The patients were randomly allocated to intervention and placebo groups, with 54 patients in each group. The allocation was concealed using sealed opaque envelopes. The intervention group received violet syrup and the control group received placebo syrup, an add-on to the conventional treatment. The outcomes were COVID-19 manifestations, such as dyspnea, cough, myalgia, headache, and diarrhea, considered as outcomes of the study and were evaluated twice using a visual analog scale before the intervention and after 7 days, at the end of the study. Patients were followed daily by phone calls to monitor proper drug consumption and possible side effects.", "No significant difference was between groups regarding demographic characteristics and vital signs before and after the treatment. Although all symptoms have improved significantly in both groups, patients who received violet syrup recovered faster and the mean severity scores of cough (P\u00a0=\u00a00.025), myalgia (P\u00a0=\u00a00.036), headache (P\u00a0=\u00a00.037), and diarrhea (P\u00a0=\u00a00.044) decreased greater in comparison to control group.", "This study, the first clinical trial on the effectiveness of Viola odorata on SARS-CoV-2 patients, showed that Viola odorata L. effectively controls prevalent manifestations of COVID-19 including cough, myalgia, headache, and diarrhea. Regarding this survey, the violet syrup can be mentioned as a complementary treatment for viral influenza-like infections in which cough, myalgia, headache, and diarrhea are prominent."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran; Traditional Persian Medicine and Complementary Medicine (PerCoMed) Student Association, Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: s-adelm@razi.tums.ac.ir."}], "LastName": "Adel Mehraban", "ForeName": "Mohammad Sadegh", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine Network (PMN), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: shirzadmd@gmail.com."}], "LastName": "Shirzad", "ForeName": "Meysam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Medicine, Medicinal Plants Research Center of Barij, Kashan, Iran. Electronic address: kashanileila138@yahoo.com."}], "LastName": "Mohammad Taghizadeh Kashani", "ForeName": "Leila", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: ahmadian.attari@gmail.com."}], "LastName": "Ahmadian-Attari", "ForeName": "Mohammad Mahdi", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: safariali1350@yahoo.com."}], "LastName": "Safari", "ForeName": "Ali Akbar", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, School of Medicine, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: ansari_narges58@yahoo.com."}], "LastName": "Ansari", "ForeName": "Narges", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: hatami@hbi.ir."}], "LastName": "Hatami", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: mkamalinejad@yahoo.com."}], "LastName": "Kamalinejad", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Randomized Controlled Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Viola"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cough"}, {"QualifierName": [], "DescriptorName": "Myalgia"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Headache"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abebe E.C., Dejenie T.A., Shiferaw M.Y., Malik T. The newly emerged COVID-19 disease: a systemic review. Virol. J. 2020;17(1):1\u20138.", "ArticleIdList": ["PMC7341708", "32641059"]}, {"Citation": "Abumansour H.M. Tehran University Press; Tehran: 1967. Abniah \u2019an Haqaeqe Al-Adviah."}, {"Citation": "Adem \u015e., Eyupoglu V., Sarfraz I., Rasul A., Zahoor A.F., Ali M., Abdalla M., Ibrahim I.M., Elfiky A.A. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomed. 2021;85", "ArticleIdList": ["PMC7442560", "32948420"]}, {"Citation": "Andrea Peirce C.P. fourth ed. Medical Economics; 2007. PDR for Herbal Medicines."}, {"Citation": "Antil V., Kumar P., Kannappan N., Diwan A., Saini P., Singh S. Evaluation of the analgesic activity of Viola odorata aerial parts in rats. J. Nat. Pharm. 2011;2(1):24. -24."}, {"Citation": "S S. Pilot clinical trial to evaluate the effectiveness of Herbal Cyclotide complex syrup as a prevention of disease complications in people exposed to COVID-19 virus. Bagheiat-allah Univ. Med. Sci. 2020"}, {"Citation": "Avicenna . 2005. Canon of Medicine Dar Ehya toras al-arabi. Beirut."}, {"Citation": "Bai Z., Li P., Wen J., Han Y., Cui Y., Zhou Y., Shi Z., Chen S., Li Q., Zhao X., Wang Z., Li R., Guo Y., Zhan X., Xu G., Ding K., Wang J., Xiao X. Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury. J. Ethnopharmacol. 2022;285", "ArticleIdList": ["PMC8590745", "34788645"]}, {"Citation": "Bone K., S M. second ed. Elsevier Ltd; 2013. Principles and Practice of Phytotherapy, Modern Herbal Medicine."}, {"Citation": "Chen Y., Liu C., Wang T., Qi J., Jia X., Zeng X., Bai J., Lu W., Deng Y., Zhong B., He W., Xing Y., Lian Z., Zhou H., Yan J., Yang X., Yu H., Zhou J., Zhou D., Qiu L., Zhong N., Wang J. Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: a multicentre, double-blind, and randomised controlled trial. J. Ethnopharmacol. 2022;284", "ArticleIdList": ["PMC8575540", "34763045"]}, {"Citation": "Cui J., Li F., Shi Z.-L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181\u2013192.", "ArticleIdList": ["PMC7097006", "30531947"]}, {"Citation": "De Felice F.G., Tovar-Moll F., Moll J., Munoz D.P., Ferreira S.T. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 2020;43(6):355\u2013357.", "ArticleIdList": ["PMC7172664", "32359765"]}, {"Citation": "Duke J.A. CRC Press; 2002. Handbook of Medicinal Herbs."}, {"Citation": "Ebrahimi Y. ninth ed. Iranian Ministry of Health; 2020. Iranian National Guideline for Diagnosis and Treatment of COVID-19 in Outpatient and Inpatient Services."}, {"Citation": "Fauci A.S., Lane H.C., Redfield R.R. Covid-19\u2014navigating the uncharted. Mass. Med. Soc. 2020", "ArticleIdList": ["PMC7121221", "32109011"]}, {"Citation": "Fazil M., Nikhat S. Therapeutic and palliative role of a unani herbal decoction in COVID-19 and similar respiratory viral illnesses: phytochemical & pharmacological perspective. J. Ethnopharmacol. 2022;115526", "ArticleIdList": ["PMC9281408", "35843408"]}, {"Citation": "Figueiredo\u2010Campos P., Blankenhaus B., Mota C., Gomes A., Serrano M., Ariotti S., Costa C., Nunes\u2010Caba\u00e7o H., Mendes A.M., Gaspar P. Seroprevalence of anti\u2010SARS\u2010CoV\u20102 antibodies in COVID\u201019 patients and healthy volunteers up to 6 months post disease onset. Eur. J. Immunol. 2020;50(12):2025\u20132040.", "ArticleIdList": ["PMC7756220", "33084029"]}, {"Citation": "Funakoshi-Tago M., Nonaka Y., Tago K., Takeda M., Ishihara Y., Sakai A., Matsutaka M., Kobata K., Tamura H. Pyrocatechol, a component of coffee, suppresses LPS-induced inflammatory responses by inhibiting NF-\u03baB and activating Nrf2. Sci. Rep. 2020;10(1):1\u201317.", "ArticleIdList": ["PMC7018815", "32054966"]}, {"Citation": "Harati E., Bahrami M., Razavi A., Kamalinejad M., Mohammadian M., Rastegar T., Sadeghipour H.R. Effects of viola tricolor flower hydroethanolic extract on lung inflammation in a mouse model of chronic asthma. Iran. J. Allergy, Asthma Immunol. 2018:409\u2013417.", "ArticleIdList": ["30518183"]}, {"Citation": "Hasan L.K., Deadwiler B., Haratian A., Bolia I.K., Weber A.E., Petrigliano F.A. Effects of COVID-19 on the musculoskeletal system: clinician's guide. Orthop. Res. Rev. 2021;13:141.", "ArticleIdList": ["PMC8464590", "34584465"]}, {"Citation": "Hong J.-M., Hu L.-H., Zhong Q.-S., Zhu L.-C., Hang Y.-P., Fang X.-Y., Sun H.-B., Huang Z.-H., Xu J., Chen Y.-H. Epidemiological characteristics and clinical features of patients infected with the COVID-19 virus in Nanchang, Jiangxi, China. Front. Med. 2020;7", "ArticleIdList": ["PMC7673370", "33251228"]}, {"Citation": "Jamshed H., Siddiqi H.S., Gilani A.U.H., Arslan J., Qasim M., Gul B. Studies on antioxidant, hepatoprotective, and vasculoprotective potential of Viola odorata and Wrightia tinctoria. Phytother Res. 2019;33(9):2310\u20132318.", "ArticleIdList": ["31209953"]}, {"Citation": "Janbaz K.H., Khan W.U., Saqib F., Khalid M. Pharmacological basis for the medicinal use of viola odorata in diarrhea, bronchial asthma and hypertension. Bangladesh. J. Pharmacol. 2015;10(4):836\u2013843."}, {"Citation": "Jorjani . Iranian Medical Academy; Tehran: 2001. Zakhireye Kharazm Shahi (Treasure of Kharazm Shah)"}, {"Citation": "Karioti A., Furlan C., Vincieri F.F., Bilia A.R. Analysis of the constituents and quality control of Viola odorata aqueous preparations by HPLC-DAD and HPLC-ESI-MS. Anal. Bioanal. Chem. 2011;399(4):1715\u20131723.", "ArticleIdList": ["21153584"]}, {"Citation": "Koochek M., Pipelzadeh M., Mardani H. The effectiveness of Viola odorata in the prevention and treatment of formalin-induced lung damage in the rat. J. Herbs, Spices, Med. Plants. 2003;10(2):95\u2013103."}, {"Citation": "Lai C.-C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55(3)", "ArticleIdList": ["PMC7127800", "32081636"]}, {"Citation": "Lamaison J., Petitjean-Freytet C., Carnat A. La fleur de violette: \u00e9tude compar\u00e9e de Viola lutea huds., V. Calcarata L. et V. Odorata L. Plant. Med. Phytother. 1991;25(2\u20133):79\u201388."}, {"Citation": "Ma Q., Xie Y., Wang Z., Lei B., Chen R., Liu B., Jiang H., Wang Y., Liu Q., Yang Z. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. J. Ethnopharmacol. 2021;279", "ArticleIdList": ["PMC8223030", "34174375"]}, {"Citation": "Mahboubi M., Kashani L.M.T. A Narrative study about the role of Viola odorata as traditional medicinal plant in management of respiratory problems. Adv. Integr. Med. 2018;5(3):112\u2013118."}, {"Citation": "Mammari N., Krier Y., Albert Q., Devocelle M., Varbanov M., OEMONOM Plant-derived antimicrobial peptides as potential antiviral agents in systemic viral infections. Pharmaceuticals. 2021;14(8):774.", "ArticleIdList": ["PMC8400714", "34451871"]}, {"Citation": "Mittal P., Gupta V., Goswami M., Thakur N., Bansal P. Phytochemical and pharmacological potential of viola odorata. Int. J. Pharmacogn. 2015;4:693."}, {"Citation": "Mosavat S.H., Marzban M., Bahrami M., Parvizi M.M., Hajimonfarednejad M. Sexual headache from view point of Avicenna and traditional Persian medicine. Neurol. Sci. 2017;38(1):193\u2013196.", "ArticleIdList": ["27770272"]}, {"Citation": "Muhammad N., Saeed M., Qayum M., Khan H. Anti-microbial Screening o f Viola betonicifolia. Middle. East. J. Sci. Res. 2013;15:55\u201360."}, {"Citation": "Nimrouzi M., Daneshfard B., Tafazoli V., Akrami R. Insomnia in traditional Persian medicine. Acta. Med. Hist. Adriat. 2019;17(1):45\u201354.", "ArticleIdList": ["31315407"]}, {"Citation": "Nosal'ova G., Strapkov\u00e1 A., Kardosov\u00e1 A., Capek P., Zathurecky L., Bukovsk\u00e1 E. Antitussive Wirkung des Extraktes und der Polysaccharide aus Eibisch (Althaea officinalis L., var. robusta) Pharm. Times. 1992;47(3):224\u2013226.", "ArticleIdList": ["1615030"]}, {"Citation": "Porrostami K., A S., Ahmadian-Attari M.M. The effect of Viola Syrup with acetaminophen syrup in comparison to acetaminophen syrup and placebo on the fever of children A Randomized and double blind clinical trial. Alborz Univ. Med. Sci. 2020"}, {"Citation": "Qasemzadeh M.J., Sharifi H., Hamedanian M., Gharehbeglou M., Heydari M., Sardari M., Akhlaghdoust M., Minae M.B. The effect of Viola odorata flower syrup on the cough of children with asthma: a double-blind, randomized controlled trial. J. Evid. Based. Complementary. Altern. Med. 2015;20(4):287\u2013291.", "ArticleIdList": ["25954025"]}, {"Citation": "Skipper C.P., Pastick K.A., Engen N.W., Bangdiwala A.S., Abassi M., Lofgren S.M., Williams D.A., Okafor E.C., Pullen M.F., Nicol M.R. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann. Intern. Med. 2020;173(8):623\u2013631.", "ArticleIdList": ["PMC7384270", "32673060"]}, {"Citation": "Tafazoli V., Shahriari M., Heydari M., Nikbakht H.A., Zarshenaas M.M., Nimrouzi M. The effect of Viola Odorata L. Oil for fever in children: a randomized triple-blinded placebo-controlled clinical trial. Curr. Drug Discov. Technol. 2020;17(5):696\u2013703.", "ArticleIdList": ["31250761"]}, {"Citation": "Tavassoli S., Eftekhari K., Karimi M., Ghobadi A., Shati M., Naddaf A., Abbassian A. Effectiveness of viola flower syrup compared with polyethylene glycol in children with functional constipation: a randomized, active-controlled clinical trial. Evid. Based. Complement. Alternat. Med. eCAM. 2021;2021", "ArticleIdList": ["PMC8452406", "34552657"]}, {"Citation": "Vaz de Paula C.B., de Azevedo M.L.V., Nagashima S., Martins A.P.C., Malaquias M.A.S., Miggiolaro A.F.R.d.S., da Silva Motta J\u00fanior J., Avelino G., do Carmo L.A.P., Carstens L.B. IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci. Rep. 2020;10(1):1\u20138.", "ArticleIdList": ["PMC7596721", "33122784"]}, {"Citation": "Weiss P., Murdoch D.R. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014\u20131015.", "ArticleIdList": ["PMC7138151", "32197108"]}, {"Citation": "Weng J.R., Lin C.S., Lai H.C., Lin Y.P., Wang C.Y., Tsai Y.C., Wu K.C., Huang S.H., Lin C.W. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273", "ArticleIdList": ["PMC7114872", "31560964"]}, {"Citation": "Whittaker A., Anson M., Harky A. Neurological manifestations of COVID\u201019: a systematic review and current update. Acta Neurol. Scand. 2020;142(1):14\u201322.", "ArticleIdList": ["PMC7273036", "32412088"]}, {"Citation": "World Health Organisation  . 2022. Health Emergency Dashboard (covid-19)https://covid19.who.int"}, {"Citation": "Xu J., Ma X.-P., Bai L., Wang M., Deng W., Ning N. A systematic review of etiology, epidemiology, clinical manifestations, image findings, and medication of 2019 Corona Virus Disease-19 in Wuhan. China. Med. 2020;99(42)", "ArticleIdList": ["PMC7572017", "33080715"]}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708.", "ArticleIdList": ["PMC7098036", "32226288"]}, {"Citation": "Yifan C., Jun P. Understanding the clinical features of coronavirus disease 2019 from the perspective of aging: a systematic review and meta-analysis. Front. Endocrinol. 2020;11", "ArticleIdList": ["PMC7686551", "33262739"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "16"}, {"Year": "2022", "Month": "12", "Day": "1"}, {"Year": "2022", "Month": "12", "Day": "13"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "19", "Hour": "19", "Minute": "13"}, {"Year": "2022", "Month": "12", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36535329", "PMC9757886", "10.1016/j.jep.2022.116058", "S0378-8741(22)01097-2"]}}], "PubmedBookArticle": []}